CMS 9123 P
FDA COVID-19 Vaccines EUA to Commercial Use
OIG Anti-Kickback Statute Safe Harbors
CMS Anti-Kickback Statute Safe Harbors
NCPDP Comments to Kentucky WC regarding Pharmacy Fee Schedule
NCPDP response to FDA request for clarification on add new Marketing Category for Drug Products Produced by Federally Registered Outsourcing Facilities (OSF)
NCPDP response to the South Carolina Workers’ Comp Commission on Proposed changes to the Medical Services Provider Manual
NCPDP’s Elite Partners provide the highest level of support for the valuable work of NCPDP in advancing patient safety and interoperability. The following Elite Partners have demonstrated intense commitment to support NCPDP’s work, vision and core values.